Skip to content
Menu
Menu
Company
Company Profile
Management
Supervisory Board
Partners
Science
Pipeline
TCR-T Cells
MDG1015
KRAS
Publications
Abstracts
End-to-End Platform
Overview
Target Screening
TCR Generation & Optimization
TCR-T Therapy Armoring & Enhancement
Manufacturing & Process Improvement
Clinical Development
Investors & Media
Press & Material News Releases
Stock Information
Analyst Coverage
Shareholder Structure
Capital Measures
Reports & Presentations
Corporate Governance & Compliance
Events
Annual General Meeting
Investor Contact
E-mail Alerts
Careers
Contact
English
Deutsch
Menu
Company
Company Profile
Management
Supervisory Board
Partners
Science
Pipeline
TCR-T Cells
MDG1015
KRAS
Publications
Abstracts
End-to-End Platform
Overview
Target Screening
TCR Generation & Optimization
TCR-T Therapy Armoring & Enhancement
Manufacturing & Process Improvement
Clinical Development
Investors & Media
Press & Material News Releases
Stock Information
Analyst Coverage
Shareholder Structure
Capital Measures
Reports & Presentations
Corporate Governance & Compliance
Events
Annual General Meeting
Investor Contact
E-mail Alerts
Careers
Contact
English
Deutsch
Investor Contact
Tel: +49 89 2000 3333 01
Contact
Pamela Keck
Vice President of Investor Relations and Corporate Communications
investor@medigene.com